Basel Medical Group interim CFO Alton Neo Chun How files initial beneficial ownership statement

BMGL•2026-07-22

Initial Form 3 filing reported for interim CFO

Basel Medical Group reported Interim CFO Neo Alton Chun How as a new Section 16 reporting officer in an initial Form 3 filing dated June 5.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-034159), on July 22, 2026, and is solely responsible for the information contained therein.

Sources

Basel Medical Group interim CFO Alton Neo Chun How files initial beneficial ownership statement

Sec

Basel Medical Group interim CFO Alton Neo Chun How files initial beneficial ownership statement

Initial Form 3 filing reported for interim CFO

Related News

OFS Capital updates financial calendar with second-quarter earnings release, conference call

bioAffinity Technologies partners with Pictor to develop asthma, COPD diagnostics

Farmers National Banc Q2 net interest income rises on Middlefield acquisition

Sources

Basel Medical Group interim CFO Alton Neo Chun How files initial beneficial ownership statement

LB Pharmaceuticals releases update on NOVA-2 Phase 3 schizophrenia trial timeline

ISS backs XFLT vote to approve King Street as sub-adviser ahead of July 30 shareholder meeting